TY  - GEN
AU  - Yu,Elmer
AU  - Miotto,Karen
AU  - Akerele,Evaristo
AU  - Montgomery,Ann
AU  - Elkashef,Ahmed
AU  - Walsh,Robert
AU  - Montoya,Ivan
AU  - Fischman,Marian W
AU  - Collins,Joseph
AU  - McSherry,Frances
AU  - Boardman,Kathy
AU  - Davies,David K
AU  - O'Brien,Charles P
AU  - Ling,Walter
AU  - Kleber,Herbert
AU  - Herman,Barbara H
TI  - A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal
SN  - 0376-8716
PY  - 2008///1216
KW  - Adrenergic alpha-Agonists
KW  - adverse effects
KW  - Adult
KW  - Analgesics, Opioid
KW  - Clonidine
KW  - Data Collection
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Psychiatric Status Rating Scales
KW  - Substance Abuse Detection
KW  - Substance Withdrawal Syndrome
KW  - drug therapy
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1016/j.drugalcdep.2008.04.002
ER  -